Johnson & Johnson shot almost approved, report of study by experts and other coronavirus news

Johnson & Johnson’s the shot nears approval, experts are examining the full scope of vaccine protection, and Covax’s international shipments begin. Here’s what you need to know:

Want to receive this weekly roundup and other coronavirus news? Register now here!


Johnson & Johnson’s single-dose vaccine close to approval in the United States

Today, a panel of experts will review the efficacy and safety of Johnson & Johnson Single Dose Covid-19 Vaccine, the last step before the FDA decides whether or not to approve the shot. This decision is expected on Saturday. Earlier this week, an FDA review found the vaccine to be 66% effective in protecting people against moderate to severe cases of Covid-19, and even more effective in protecting against serious illness. J&J said if approved it would deliver around 20 million doses to the United States by the end of March.

In addition, two other vaccines, Novavax and AstraZeneca, plan to apply for emergency use authorization in the United States in April. And Pfizer and Moderna both told U.S. lawmakers this week that they expected a major increase in vaccine deliveries over the next five weeks, claiming to have overcome manufacturing challenges. From Thursday, 6.5 percent of the United States had been fully vaccinated and nearly 14 percent had received the first dose. All vaccine news from the past week indicates that these numbers will continue to rise.

Experts examine whether vaccines reduce transmission and protect against variants

This week, two new studies – which have yet to be peer reviewed – made headlines announcing that vaccinations reduce viral spread. Experts not affiliated with the studies say they have flaws and can’t realistically tell us how many vaccines reduce transmission, but the good news is they show vaccines work well. For now, public health officials say: stay masked and vigilant, even when vaccinated.

Meanwhile, Moderna and Pfizer are working to modify their vaccines to better protect them against the variants. Moderna announced on Wednesday that a new version of its vaccine designed to target the variant first found in South Africa is ready for human testing. And Pfizer said it was considering adding a third booster dose to specifically target the same mutation.

International vaccine distribution is increasing

This week, the WHO-led Covax initiative, which aims to distribute vaccines equitably around the world, sent its first shipments to Ghana and the Ivory Coast, a milestone for the global distribution of vaccines. Covax received the the vast majority of its funds from G7 countries and the EU. Other countries, including China, India and Russia, have also launched their own so-called vaccine diplomacy efforts, even as they face their own national challenges.

Within the EU, efforts are also underway to accelerate vaccine deployment. Leaders from the region gathered this week and stressed the importance of speeding up vaccine production and delivery. They also discussed the idea of ​​“vaccination certificates”, which could make tourism and travel during the summer holidays possible.

Daily distraction

Black characters in video games have come a long way. But we always need more of them.

Something to read

Where do celebrity gossip sites come from? How are famous people’s sex tapes sold? And what other deals are being made to keep the dirty secrets of famous people off the internet? For 20 years, celebrity fixer Kevin Blatt has been at the at the center of everything.

Sanitary verification

Spring is almost here, which means it’s a great time to shop for winter clothes on sale. Here are some of the best offers of the season.

A question

What is it like to live odorless?

Many have become more aware of smell disorders over the past year, as thousands of people with Covid-19 have lost their sense of smell, sometimes for months. But odor disturbances are in fact deceptively common. Losing all or part of your sense of smell Can be confusing, to say the least: you can’t sense scent memories or taste food the same way. And there are health and safety issues that the condition presents, such as missing gas leaks or the inability to know when food is spoiled.

More WIRED on Covid-19

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *